Our Fight Against Cancer
Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients with unmet medical needs.
Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel cancer therapies.
A Pipeline of Breakthrough Cancer Therapeutics
VAL-083 is a first-in-class small molecule DNA-targeting agent that exhibits a novel mechanism of action that results in DNA double strand breaks and cancer cell death. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types.
VAL-083's indications include:
Glioblastoma Multiforme (GBM)
Ovarian Cancer
Pediatric CNS Tumors
REM-001 is a second generation photosensitizer drug possessing multiple advantages over earlier generation PDT compounds.
REM-001’s indications include:
Cutaneous Metastatic Breast Cancer
Recurrent Basal Cell Carcinoma Nevus Syndrome
Hemodialysis Arteriovenous (AV) Access
Company Details
- Employees
- 5
- Address
- 12707 High Bluff Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.kintara.com/
- Keywords
- Cancer, Glioblastoma Multiforme, GBM, Ovarian Cancer, Pediatric CNS Tumors, Cutaneous Metastatic Breast Cancer, Recurrent Basal Cell Carcinoma Nevus Syndrome, Hemodialysis Arteriovenous (AV) Access.
- HQ
- San Diego, California
Kintara Therapeutics, Inc. Nasdaq: Ktra Questions
Kintara Therapeutics, Inc. Nasdaq: Ktra's website is https://www.kintara.com/
Kintara Therapeutics, Inc. Nasdaq: Ktra's LinkedIn profile is https://www.linkedin.com/company/kintara-therapeutics
Kintara Therapeutics, Inc. Nasdaq: Ktra has
5 employees.
View email and phone details for 5
employees at Kintara Therapeutics, Inc. Nasdaq: Ktra.
Kintara Therapeutics, Inc. Nasdaq: Ktra's industry is
Biotechnology Research
Kintara Therapeutics, Inc. Nasdaq: Ktra's top competitors are
Tuhura Biosciences, Inc.,
Janux Therapeutics,
Kineta,
Viking Therapeutics, Inc.,
Abceutics Inc.,
Kura Oncology, Inc.,
Meowsprout Therapeutics,
Regencor Inc.,
Innovo Therapeutics,
Tuhura Biosciences.
Kintara Therapeutics, Inc. Nasdaq: Ktra's categories are Biotechnology Research
